Anne Sofie Siebuhr

9PUBLICATIONS
12CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Autonomic nervous systemMolecular targetsMedical biochemistry - inorganic elements and compoundsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 22, 2021
Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.

Signe Holm Nielsen, Samra Sardar, Anne Sofie Siebuhr

|Mar 30, 2021
Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?

Anne C Bay-Jensen, Anne Sofie Siebuhr, Dres Damgaard

|Aug 23, 2020
The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo.

Anne Sofie Siebuhr, Daniela Werkmann, Anne-C Bay-Jensen

|Aug 21, 2020
Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.

Markéta Hušáková, Anne-C Bay-Jensen, Šárka Forejtová

|Apr 09, 2020
Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivo.

D Reker, A S Siebuhr, C S Thudium

|Aug 04, 2019
Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.

Markéta Hušáková, Anne-C Bay-Jensen, Šárka Forejtová

Pageof 2

Frequent Collaborators

4 joint publications

Anne-Christine Bay-Jensen

1 joint publications

A Aspberg

1 joint publications

Desirée van der Heijde

1 joint publications

Pernille Juhl